Do we really need moderate to high dose aspirin in treatment of Kawasaki disease ?
Not Applicable
- Conditions
- Health Condition 1: M303- Mucocutaneous lymph node syndrome[Kawasaki]
- Registration Number
- CTRI/2024/06/068247
- Lead Sponsor
- INSTITUTE OF CHILD HEALTH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Children with KD diagnosed as per AHA 2017 guidelines and receiving low dose aspirin @5mg/kg
Exclusion Criteria
Patient receiving high or moderate dose aspirin more than 30mg/kg or infliximab or steroids .
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method